These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 46529)

  • 21. Effect of chlorpropamide on serum glucose and immunoreactive insulin concentrations in patients with maturity-onset diabetes mellitus.
    Reaven G; Dray J
    Diabetes; 1967 Jul; 16(7):487-92. PubMed ID: 6028757
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical comparison between glibornuride (Glutril) and glibenclamide in maturity-onset diabetes: a controlled double-blind trial.
    Mogensen EF; Worm J; Mikkelsen BO
    Curr Ther Res Clin Exp; 1976 Jun; 19(6):559-64. PubMed ID: 132338
    [No Abstract]   [Full Text] [Related]  

  • 23. The use of a nurse practitioner in the management of patients with diabetes mellitus.
    Stein GH
    Med Care; 1974 Oct; 12(10):885-90. PubMed ID: 4437220
    [No Abstract]   [Full Text] [Related]  

  • 24. [Reaction of diabetic carbohydrate metabolism on the change from chlorpropamide to glibenclamide].
    Henning H; Look D
    Dtsch Med J; 1972 Oct; 23(10):634-6. PubMed ID: 4630502
    [No Abstract]   [Full Text] [Related]  

  • 25. Glyburide.
    Med Lett Drugs Ther; 1976 Jun; 18(13):54-5. PubMed ID: 819766
    [No Abstract]   [Full Text] [Related]  

  • 26. Abnormal serum growth hormone response to exercise in maturity-onset diabetics.
    Hansen AP
    Diabetes; 1973 Aug; 22(8):619-28. PubMed ID: 4724236
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical assessment of glybenclamide (daonil) in diabetes mellitus.
    Tripathy BB; Kar BC; Tej SC; Panda NC; Parija CR
    J Assoc Physicians India; 1973 Mar; 21(3):263-73. PubMed ID: 4210050
    [No Abstract]   [Full Text] [Related]  

  • 28. Chlorpropamide and fibrinolytic activity in maturity onset diabetes mellitus.
    Alexander WD; Wensley RT; Price G; Hartog M
    Postgrad Med J; 1976 May; 52(607):251-3. PubMed ID: 959097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Glibenclamide, a new oral antidiabetic].
    Edlén A
    Lakartidningen; 1972 Jan; 69(4):342-3. PubMed ID: 4622487
    [No Abstract]   [Full Text] [Related]  

  • 30. Correlation between serum concentration and hypoglycemic effect of chlorpropamide in man.
    Jankowski A; Wichliński LM; Bokowski W; Romański B
    Pol J Pharmacol Pharm; 1984; 36(5):449-53. PubMed ID: 6533629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of control of blood glucose on plasma insulin responses to various stimuli in secondary failures to oral hypoglycemic agents and in newly diagnosed, maturity onset, ketosis-resistant diabetics.
    Schmeltz R; Wendorff HJ; Field JB
    J Clin Endocrinol Metab; 1978 Apr; 46(4):519-27. PubMed ID: 755038
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of a new oral drug in the treatment of diabetes mellitus].
    Lubetzki J
    Diabete; 1971; 19(3):185-90. PubMed ID: 5002990
    [No Abstract]   [Full Text] [Related]  

  • 33. Glucose variability.
    Service FJ
    Diabetes; 2013 May; 62(5):1398-404. PubMed ID: 23613565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Therapeutic activity of a glibenclamide-phenformin association in maturity-onset diabetes].
    Gervasini A
    Minerva Med; 1974 Oct; 65(73):3835-42. PubMed ID: 4214284
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment with glibenclamide in maturity-onset diabetes mellitus.
    Persson I; Madsen SN
    Geriatrics; 1971 May; 26(5):182-3 passim. PubMed ID: 4997365
    [No Abstract]   [Full Text] [Related]  

  • 36. Home blood glucose concentrations in maturity-onset diabetes.
    Paisey RB; Bradshaw P; Hartog M
    Br Med J; 1980 Mar; 280(6214):596-8. PubMed ID: 7370601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chlorpropamide in treatment of elderly diabetic patients.
    Shuman CR
    Geriatrics; 1968 Aug; 23(8):142-7. PubMed ID: 5661958
    [No Abstract]   [Full Text] [Related]  

  • 38. Weight loss reverses secondary failure of oral hypoglycaemic agents in obese non-insulin-dependent diabetic patients independently of the duration of the disease.
    Pontiroli AE; Calderara A; Pacchioni M; Cassisa C; Pozza G
    Diabete Metab; 1993; 19(1):30-5. PubMed ID: 8504882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of treatment with diet alone on oral glucose-tolerance test and plasma sugar and insulin levels in patients with maturity-onset diabetes mellitus.
    Doar JW; Wilde CE; Thompson ME; Sewell PF
    Lancet; 1975 Jun; 1(7919):1263-6. PubMed ID: 48896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum tolbutamide and chlorpropamide concentrations in patients with diabetes mellitus.
    Melander A; Sartor G; Wåhlin E; Scherstén B; Bitzén PO
    Br Med J; 1978 Jan; 1(6106):142-4. PubMed ID: 620227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.